Search
With our world-class researchers delivering world-leading research, we're always announcing exciting news. See the latest from Telethon Kids Institute.
Australia’s new respiratory syncytial virus (RSV) immunisation program cut hospital admissions for Australia’s youngest babies by almost half in its first year, a new major national study has shown.
Preclinical research from the WA Comprehensive Kids Cancer Centre has revealed a promising new strategy to protect bone health in children with high-risk B-cell acute lymphoblastic leukaemia (B-ALL), showing that actively rebuilding bone may deliver faster and more effective protection against debilitating fractur
The Kids Research Institute Australia strongly endorses the updated framework, which reinforces the essential role consumers and communities play in shaping better research outcomes.
Professor Caroline Homer AO - a globally recognised leader in maternal and child health, with an international career that spans clinical care, academic research, policy influence and senior leadership - has been named The Kids Research Institute Australia’s third Executive Director.
Recently, researchers from The Kids Research Institute Australia, Perth Children’s Hospital and The University of Western Australia contributed to three major international publications, collectively reinforcing rare diseases as a critical, community-wide health priority.
A leading autism scientist has relocated to Perth to take up a new appointment at The Kids Research Institute Australia, thanks to a program designed to attract world-class health researchers to Western Australia.
Coming up in 2021 Contact us We have a a study to suit every age range in 2021! From babies at just six weeks for the FluBub Study, through to
Contact us If you'd like to get in touch, please contact us by phone or email. Phone: 0400 450 240 Email: vtg@thekids.org.au Pneumococcal disease is
Contact us If you'd like to get in touch, please contact us by phone or email. Phone: 0400 450 240 Email: vtg@thekids.org.au The Vaccine Trials Group